Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-01 Wang Xiaodong Director Sale −1,100 $347.32 $382K 3,011
2021-07-01 Wang Xiaodong Director Sale −1,500 $348.64 $523K 1,511
2021-07-01 Wang Xiaodong Director Sale −1,211 $349.89 $424K 300
2021-07-01 Wang Xiaodong Director Sale −300 $350.59 $105K 0
2021-07-01 Wang Julia Aijun Chief Financial Officer Sale −308 $349.06 $108K 0
2021-06-29 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2021-06-29 Huang Jane CMO, Hematology Sale −300 $347.63 $104K 1,200
2021-06-29 Huang Jane CMO, Hematology Sale −100 $349.22 $35K 1,100
2021-06-29 Huang Jane CMO, Hematology Sale −400 $351.06 $140K 700
2021-06-29 Huang Jane CMO, Hematology Sale −200 $352.95 $71K 500
2021-06-29 Huang Jane CMO, Hematology Sale −300 $355.26 $107K 200
2021-06-29 Huang Jane CMO, Hematology Sale −200 $356.98 $71K 0
2021-06-29 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 207,575
2021-06-28 Huang Jane CMO, Hematology Sale −425 $365.00 $155K 0
2021-06-28 Wang Lai Global Head of R&D Sale −455 $362.48 $165K 0
2021-06-28 Liang Howard CFO & Chief Strategy Officer Sale −446 $365.00 $163K 0
2021-06-18 Wu Xiaobin President, COO & GM China Sale −1,156 $330.93 $383K 0
2021-06-18 Wang Lai Global Head of R&D Sale −802 $331.15 $266K 0
2021-06-18 Huang Jane CMO, Hematology Sale −469 $325.66 $153K 0
2021-06-18 Liang Howard CFO & Chief Strategy Officer Sale −486 $325.89 $158K 0

Page 68 of 99 · 1,972 trades